Evome Medical Technologies (LNDZF) Stock Price, News & Analysis

Company Overview

Evome Medical Technologies Inc., through its subsidiaries, engages in the development, production, and sale of medical devices and products in the United States. The company's medical devices are used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, and ultrasound treatment devices. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. Evome Medical Technologies Inc. is headquartered in Shirley, New York.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.04 to $0.15
• 52-Week Range: $0.01 to $0.21
• Volume: N/A
• Average Volume: 8,365 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LNDZF Stock Analysis - Frequently Asked Questions

How have LNDZF shares performed this year?

Evome Medical Technologies' stock was trading at $0.1516 at the beginning of 2024. Since then, LNDZF shares have decreased by 65.6% and is now trading at $0.0521.
View the best growth stocks for 2024 here.

How do I buy shares of Evome Medical Technologies?

Shares of LNDZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:LNDZF
• CUSIP: N/A
• CIK: 1617765
• Web: www.inspirafin.ca
• Phone: (800) 760-6826
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A